Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis?

MLA

van den Heuvel, Dianne M. A., et al. “Taking a Risk: A Therapeutic Focus on Ataxin-2 in Amyotrophic Lateral Sclerosis?” Trends in Molecular Medicine, vol. 20, no. 1, Jan. 2014, pp. 25–35. EBSCOhost, https://doi.org/10.1016/j.molmed.2013.09.001.

APA

van den Heuvel, D. M. A., Harschnitz, O., van den Berg, L. H., & Pasterkamp, R. J. (2014). Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis? Trends in Molecular Medicine, 20(1), 25–35. https://doi.org/10.1016/j.molmed.2013.09.001

Chicago

van den Heuvel, Dianne M.A., Oliver Harschnitz, Leonard H. van den Berg, and R. Jeroen Pasterkamp. 2014. “Taking a Risk: A Therapeutic Focus on Ataxin-2 in Amyotrophic Lateral Sclerosis?” Trends in Molecular Medicine 20 (1): 25–35. doi:10.1016/j.molmed.2013.09.001.